The role of berberine in polycystic ovary syndrome - a summary of knowledge.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing prior literature without systematic review methodology
PubMed 38108460 · doi:10.5603/gpl.95138
What was done
This paper is a narrative review summarizing existing literature on the therapeutic role, hormonal effects, and safety profile of berberine in women with polycystic ovary syndrome (PCOS).
What was found
The abstract reports no numerical data, effect sizes, or statistical metrics. It states that prior studies show berberine decreases testosterone and free androgen index (FAI), increases sex hormone-binding globulin (SHBG), improves clinical features of androgen excess (acne and hirsutism), and enhances the effects of metformin and oral contraceptive pills with a favourable safety profile.
Why it matters
It highlights berberine as a potential adjunct or alternative pharmacological option for managing hyperandrogenism and metabolic features in PCOS.
Limits
As a narrative review, it lacks a systematic search protocol, risk-of-bias evaluation, and meta-analytic synthesis. The abstract provides no quantitative data, participant numbers, dosing regimens, or specific safety outcomes.
Cited by
- context Studies indicate that long-term use of berberine is not advised.